✦ LIBER ✦

TP53 and P21 polymorphisms: Response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer

✍ Scribed by Alexandra M. Santos; Hugo Sousa; Catarina Portela; Deolinda Pereira; Daniela Pinto; Raquel Catarino; Carla Rodrigues; Ana P. Araújo; Carlos Lopes; Rui Medeiros

Book ID: 116291974
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 264 KB
Volume: 340
Category: Article
ISSN: 0006-291X
DOI: 10.1016/j.bbrc.2005.11.176

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p53 overexpression is associated with cy

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer

✍ Ferrandina, G; Fagotti, A; Salerno, M G; Natali, P G; Mottolese, M; Maneschi, F; 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 188 KB

MC13-0045 Genes from the TP53 network an

MC13-0045 Genes from the TP53 network and their role in ovarian cancer prognosis and response to chemotherapy

✍ Podgorska, A.; Szafron, L.; Felisiak-Golabek, A.; Kupryjanczyk, J. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 114 KB

GST genetic polymorphisms and disease ou

GST genetic polymorphisms and disease outcome after platinum/paclitaxel based chemotherapy in advanced ovarian carcinoma

✍ R. Medeiros; M. Freitas-Silva; N. Afonso; C. Palmeira; C. Afonso-Lopes; A. Vasco 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 184 KB

BRCA1 and implications for response to c

BRCA1 and implications for response to chemotherapy in ovarian cancer

✍ Jennifer E. Quinn; Judith E. Carser; Colin R. James; Richard D. Kennedy; D. Paul 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 689 KB

Body Size and Response to Chemotherapy i

Body Size and Response to Chemotherapy in Ovarian Cancer Patients

✍ E. Brown; P. Brevard; J. Pearson; R. Travis; R. Domangue 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 156 KB

TUMOUR CELL MORPHOMETRY AND RESPONSE TO

TUMOUR CELL MORPHOMETRY AND RESPONSE TO CHEMOTHERAPY IN OVARIAN CANCER

✍ WEGER, A 📂 Article 📅 1988 🏛 The Lancet 🌐 English ⚖ 347 KB